Thank you for donating!

You can donate using the following services.

Need support today?

Main menu

News

  1. 21.10.20

    Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment per US FDA

    Read more

  2. 19.10.20

    IntraBio Reports Further Detail on Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C

    Read more

  3. 19.10.20

    "Illustrate your Imagination" (Orphazyme)

    Read more

  4. 30.09.20

    IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C

    Read more

  5. 16.09.20

    Orphazyme announces U.S. FDA acceptance and Priority Review of New Drug Application for arimoclomol for Niemann-Pick disease Type C

    Read more

2021 Niemann-Pick UK (NPUK). Registered Charity: England and Wales (1144406) / Scotland (SCO45407). Registered as a company limited by guarantee in England and Wales (07775835).

Donate today